Pharmacologic inhibition of PI3K either with a reversible inhibitor LY or an irreversible inhibitor wortmanin significantly reduced DNA binding activity of NFkB in activin treated FET colon cancer cells (Figure 3C and 3D). Here, INHBE is linked to malignant colon neoplasm.